The expression of type III hyperlipoproteinemia: involvement of lipolysis genes-Reference-Cited by-同舟云学术

The expression of type III hyperlipoproteinemia: involvement of lipolysis genes

Published:2008-11-26 Issue:5 Volume:17 Page:620-628
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Henneman Peter,van der Sman-de Beer Femke,Moghaddam Payman Hanifi,Huijts Petra,Stalenhoef Anton FH,Kastelein John JP,van Duijn Cornelia M,Havekes Louis M,Frants Rune R,van Dijk Ko Willems,Smelt Augustinus HM

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/ejhg2008202.pdf

Reference50 articles.

1. Morganroth J, Levy RI, Fredrickson DS : The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann Intern Med 1975; 82: 158–174.

2. Brewer Jr HB, Zech LA, Gregg RE, Schwartz D, Schaefer EJ : NIH Conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med 1983; 98: 623–640.

3. Smelt AH, de Beer F : Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects. Semin Vasc Med 2004; 4: 249–257.

4. Mahley RW, Rall Jr SC : Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507–537.

5. Utermann G : Apolipoprotein E polymorphism in health and disease. Am Heart J 1987; 113: 433–440.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. APOE–NOTCH axis governs elastogenesis during human cardiac valve remodeling;Nature Cardiovascular Research;2024-07-24

2. Biomolecular Actions by Intestinal Endotoxemia in Metabolic Syndrome;International Journal of Molecular Sciences;2024-02-29

3. Apolipoprotein E-ε2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study;Circulation Research;2024-02-16

4. Implications of stem cell–associated signals in pathogenesis of lipid disorders;Stem Cells and Signaling Pathways;2024

5. Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemia;Journal of Clinical Lipidology;2023-11